HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.

Research output: Contribution to journalArticle

Original languageEnglish
JournalCancer discovery
Publication statusPublished - 2012

Cite this